Your browser doesn't support javascript.
loading
Circulating tumor cell quantification during abiraterone plus prednisone therapy may estimate survival in metastatic castration-resistant prostate cancer patients.
Gu, Tengfei; Li, Jie; Chen, Ting; Zhu, Qingfeng; Ding, Jiafeng.
Afiliación
  • Gu T; Department of Urology, Lishui Municiple Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, No. 289 Kuocang Road, 323000, Lishui, China.
  • Li J; Department of Urology, Lishui Municiple Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, No. 289 Kuocang Road, 323000, Lishui, China.
  • Chen T; Department of Urology, Lishui Municiple Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, No. 289 Kuocang Road, 323000, Lishui, China.
  • Zhu Q; Department of Urology, Lishui Municiple Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, No. 289 Kuocang Road, 323000, Lishui, China.
  • Ding J; Department of Urology, Lishui Municiple Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, No. 289 Kuocang Road, 323000, Lishui, China. fen24840723@163.com.
Int Urol Nephrol ; 55(4): 883-892, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36709467

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Células Neoplásicas Circulantes Límite: Humans / Male Idioma: En Revista: Int Urol Nephrol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Células Neoplásicas Circulantes Límite: Humans / Male Idioma: En Revista: Int Urol Nephrol Año: 2023 Tipo del documento: Article País de afiliación: China
...